SEC Filing Details
Document Details
Form
Filing Date
Aug 12, 2021
Document Date
Aug 10, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Arcturus Therapeutics, Inc.
Issuer
Arcturus Therapeutics Holdings Inc.
Filer
Ultragenyx Pharmaceutical Inc.